Literature DB >> 19905934

Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.

Stefano Menzo, Donatella Vincenti, Mariacarmela Solmone, Mattia Prosperi, Alessandro Bruselles, Isabella Abbate, Gabriella Rozera, Maria Rosaria Capobianchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19905934     DOI： 10.1086/647991

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25

2.  Dynamics of mitochondrial heteroplasmy in three families investigated via a repeatable re-sequencing study.

Authors:  Hiroki Goto; Benjamin Dickins; Enis Afgan; Ian M Paul; James Taylor; Kateryna D Makova; Anton Nekrutenko
Journal:  Genome Biol       Date:  2011-06-23       Impact factor: 13.583

3.  Benefits and Challenges with Applying Unique Molecular Identifiers in Next Generation Sequencing to Detect Low Frequency Mutations.

Authors:  Ruqin Kou; Ham Lam; Hairong Duan; Li Ye; Narisra Jongkam; Weizhi Chen; Shifang Zhang; Shihong Li
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

4.  Association of preexisting drug-resistance mutations and treatment failure in hepatitis B patients.

Authors:  Jie Ma; Yingchun Zhang; Xinyue Chen; Yi Jin; Dexi Chen; Yun Wu; Jing Cui; Haitao Wang; Jia Liu; Ning Li; Feng Gao
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.